PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+9.42%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$5.41B
AUM Growth
+$1.18B
(+28%)
Cap. Flow
+$972M
Cap. Flow
% of AUM
17.96%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
1,158
New
152
Increased
697
Reduced
246
Closed
52
Top Buys
| 1 |
Alibaba
BABA
|
$59.8M |
| 2 |
JD.com
JD
|
$41.3M |
| 3 |
Mercado Libre
MELI
|
$35.1M |
| 4 |
NetEase
NTES
|
$34.7M |
| 5 |
KE Holdings
BEKE
|
$19.5M |
Top Sells
| 1 |
Futu Holdings
FUTU
|
$27.8M |
| 2 |
Trip.com Group
TCOM
|
$21.9M |
| 3 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
$12.1M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
$12M |
| 5 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
$11.2M |
Sector Composition
| 1 | Consumer Discretionary | 33.74% |
| 2 | Technology | 22.72% |
| 3 | Communication Services | 13.35% |
| 4 | Industrials | 4.85% |
| 5 | Real Estate | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Sangamo Therapeutics
SGMO
$165M
| $40K | ﹤0.01% |
3,255
-15
| -0.5% | -$184 |
|
|
VAR
852
DELISTED
Varian Medical Systems, Inc.
VAR
| $40K | ﹤0.01% |
229
+37
| +19% | +$6.46K |
|
|
PAND
853
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $40K | ﹤0.01% |
670
-30
| -4% | -$1.79K |
|
854
Cincinnati Financial
CINF
$24B
| $39K | ﹤0.01% |
388
+60
| +18% | +$6.03K |
|
855
Gartner
IT
$18.6B
| $39K | ﹤0.01% |
215
+32
| +17% | +$5.81K |
|
856
Omnicom Group
OMC
$15.4B
| $39K | ﹤0.01% |
532
+80
| +18% | +$5.87K |
|
857
SS&C Technologies
SSNC
$21.7B
| $39K | ﹤0.01% |
567
+88
| +18% | +$6.05K |
|
858
Zentalis Pharmaceuticals
ZNTL
$126M
| $39K | ﹤0.01% |
915
-15
| -2% | -$639 |
|
859
Cable One
CABO
$922M
| $38K | ﹤0.01% |
21
+8
| +62% | +$14.5K |
|
860
IDEX
IEX
$12.4B
| $38K | ﹤0.01% |
184
+26
| +16% | +$5.37K |
|
861
Krystal Biotech
KRYS
$4.35B
| $38K | ﹤0.01% |
500
+50
| +11% | +$3.8K |
|
862
Scholar Rock
SRRK
$3.02B
| $38K | ﹤0.01% |
765
-5
| -0.6% | -$248 |
|
|
DRE
863
DELISTED
Duke Realty Corp.
DRE
| $38K | ﹤0.01% |
930
+144
| +18% | +$5.88K |
|
|
ENDP
864
DELISTED
Endo International plc
ENDP
| $38K | ﹤0.01% |
5,215
-130
| -2% | -$947 |
|
865
Arch Capital
ACGL
$34.1B
| $37K | ﹤0.01% |
987
+152
| +18% | +$5.7K |
|
866
Aurinia Pharmaceuticals
AUPH
$1.63B
| $37K | ﹤0.01% |
2,885
-55
| -2% | -$705 |
|
867
Castle Biosciences
CSTL
$683M
| $37K | ﹤0.01% |
555
+95
| +21% | +$6.33K |
|
868
Cytokinetics
CYTK
$6.34B
| $37K | ﹤0.01% |
1,605
-20
| -1% | -$461 |
|
869
Raymond James Financial
RJF
$33B
| $37K | ﹤0.01% |
461
+72
| +19% | +$5.78K |
|
|
ZEN
870
DELISTED
ZENDESK INC
ZEN
| $37K | ﹤0.01% |
285
+44
| +18% | +$5.71K |
|
|
FPRX
871
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $37K | ﹤0.01% |
990
-75
| -7% | -$2.8K |
|
872
Alector
ALEC
$305M
| $36K | ﹤0.01% |
1,800
-40
| -2% | -$800 |
|
873
Boston Properties
BXP
$12.2B
| $36K | ﹤0.01% |
358
+56
| +19% | +$5.63K |
|
874
Generation Bio
GBIO
$40.3M
| $35K | ﹤0.01% |
123
+15
| +14% | +$4.27K |
|
875
Genmab
GMAB
$16.9B
| $35K | ﹤0.01% |
1,080
+5
| +0.5% | +$162 |
|